CLINICAL_TRIALS
trial_result
· 2014-12-03
Clinical Trial Update: A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Summary
Phase 2 study evaluating lenalidomide in Japanese patients with newly diagnosed multiple myeloma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-12-03